$270.93—Stale · unknown old
NYSE • Last print unknown ago
$270.93—Stale · unknown old
First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that invests in biotechnology companies primarily located in the United States. The fund's performance is driven by the growth of the biotech sector, particularly in areas such as drug development and innovative therapies.
FBT generates revenue through management fees based on the total assets under management. The fund's focus on biotechnology allows it to capitalize on the sector's growth potential, driven by advancements in medical research and increasing healthcare expenditures.
Performance of underlying biotech stocks, particularly in drug development and gene therapy
Regulatory approvals for biotech products
Mergers and acquisitions within the biotech sector
Market sentiment towards healthcare and biotech investments
Regulatory changes affecting drug approvals and pricing
Technological disruption in biotechnology and pharmaceuticals
Increased competition from other biotech-focused ETFs
Market volatility impacting investor sentiment towards biotech
Limited liquidity in smaller biotech stocks within the fund
Potential for high volatility in AUM based on market performance
moderate - The biotech sector can be sensitive to economic cycles, as healthcare spending may fluctuate with consumer confidence and disposable income.
Higher interest rates can increase the cost of capital for biotech firms, potentially slowing innovation and investment in the sector, which could negatively impact FBT's performance.
minimal - The fund is not heavily reliant on credit markets.
growth - Investors looking for exposure to high-growth biotech companies.
high - The fund is likely to exhibit high volatility due to the nature of biotech stocks.